Meghraj Vivekanand Suryawanshi | Pharmaceutics | Innovative Research Award

Published-on by Indian Scientist

Innovative Research Award

Meghraj Vivekanand Suryawanshi
Affiliation Savitribai Phule Pune University
Country India
Scopus ID 58037948200
Documents 48
Citations 104
h-index 5
Subject Area Pharmaceutics
Event Indian Scientist Awards
ORCID 0000-0003-3958-2813

Meghraj Vivekanand Suryawanshi

Savitribai Phule Pune University, India

Meghraj Vivekanand Suryawanshi has contributed to the field of Pharmaceutics through research activities reflected in indexed publications, citations, and measurable scholarly impact. His academic profile demonstrates sustained engagement in pharmaceutical sciences and related research domains, supporting scientific knowledge dissemination and interdisciplinary collaboration.[1][2]

Abstract

This article presents an academic overview of Meghraj Vivekanand Suryawanshi and his scholarly contributions within the field of Pharmaceutics. The profile highlights publication activity, citation performance, research engagement, and academic impact indicators documented through internationally recognized indexing platforms. The assessment considers research productivity, contribution to pharmaceutical sciences, and relevance to innovation-oriented scientific recognition programs.[1]

Keywords

Pharmaceutics, Drug Delivery Systems, Pharmaceutical Research, Scientific Innovation, Research Impact, Scholarly Publications, Citation Analysis, Academic Recognition, Pharmaceutical Sciences, Innovative Research Award.

Introduction

Research in pharmaceutics plays a fundamental role in improving therapeutic outcomes, formulation technologies, drug delivery mechanisms, and pharmaceutical manufacturing processes. Academic researchers contribute to the advancement of healthcare through experimental investigations, translational research, and dissemination of scientific findings. Meghraj Vivekanand Suryawanshi’s scholarly profile reflects active participation in these efforts through publication and citation records indexed in major academic databases.[1]

Research Profile

Meghraj Vivekanand Suryawanshi is affiliated with Savitribai Phule Pune University, a recognized institution engaged in higher education and scientific research. His documented scholarly profile includes research publications indexed in Scopus, demonstrating contributions to pharmaceutical sciences and related disciplines.[1]

  • Institutional Affiliation: Savitribai Phule Pune University.
  • Country of Research Activity: India.
  • Scopus Indexed Documents: 48.
  • Citation Count: 104.
  • h-index: 5.
  • Primary Subject Area: Pharmaceutics.

Research Contributions

The research contributions associated with this profile encompass pharmaceutical formulation studies, drug delivery approaches, evaluation methodologies, and related pharmaceutical investigations. Such work supports the broader objective of improving therapeutic effectiveness and scientific understanding within the pharmaceutical sector.[3]

  • Development and evaluation of pharmaceutical formulations.
  • Investigation of drug delivery technologies.
  • Research supporting pharmaceutical quality and efficacy assessment.
  • Contribution to peer-reviewed scientific literature.
  • Participation in collaborative and interdisciplinary research activities.

Publications

Publication activity serves as an important indicator of academic productivity. The available bibliometric profile demonstrates a record of peer-reviewed outputs that contribute to knowledge generation in pharmaceutical sciences and allied research areas.[1]

  1. Research articles indexed in international scientific databases.
  2. Studies related to pharmaceutical formulation and evaluation.
  3. Scientific communications supporting evidence-based pharmaceutical development.
  4. Collaborative publications contributing to interdisciplinary knowledge exchange.

Research Impact

Research impact may be evaluated through bibliometric indicators including publication volume, citation performance, and h-index metrics. With 48 indexed documents, 104 citations, and an h-index of 5, the profile demonstrates measurable scholarly visibility within the academic community.[1]

  • Evidence of sustained scholarly publication activity.
  • Research findings referenced by other investigators.
  • Contribution to scientific discourse within pharmaceutics.
  • Academic visibility reflected through citation metrics.

Award Suitability

The Innovative Research Award recognizes researchers whose scholarly activities contribute to scientific advancement and innovation. Based on the documented research profile, publication record, citation indicators, and engagement in pharmaceutical sciences, Meghraj Vivekanand Suryawanshi demonstrates attributes commonly associated with academic recognition programs emphasizing innovation, research productivity, and knowledge dissemination.[1][2]

Conclusion

Meghraj Vivekanand Suryawanshi’s academic profile reflects sustained participation in pharmaceutical research and scholarly publication. Through documented contributions in Pharmaceutics, indexed publications, citation performance, and measurable research indicators, the profile represents ongoing engagement with scientific inquiry and evidence-based knowledge development. These characteristics align with the objectives of professional research recognition initiatives such as the Innovative Research Award.[1]

References

  1. Scopus author details: Meghraj Vivekanand Suryawanshi, Author ID 58037948200. Scopus.https://www.scopus.com/authid/detail.uri?authorId=58037948200
  2. Medicinal and Nutritional Importance of Hypericum perforatum in Human Health.https://link.springer.com/chapter/10.1007/978-981-95-3620-7_13
  3. Neuroprotective efficacy of Nyctanthes arbor-tristis in a rotenone-induced rat model of Parkinson’s disease

    https://www.sciencedirect.com/science/article/abs/pii/S0378874126006781?via%3Dihub

Yogeeta Agrawal | Pharmaceutical Sciences | Best Researcher Award

Published-on by Indian Scientist

Prof. Dr. Yogeeta Agrawal | Pharmaceutical Sciences | Best Researcher Award

SVKM NMIMS Global University | India

Dr. Yogeeta Agrawal Goyal is a Professor of Pharmaceutics at SVKM NMIMS Global University, Dhule, with more than 19 years of teaching and research experience. She holds a Ph.D. from Jaipur National University with research at AIIMS New Delhi, an M.Pharm with distinction and gold medal from The M.S. University of Baroda, a B.Pharm with multiple university gold medals from Nagpur University, and a PG Diploma in Patent Law from NALSAR University. Her research expertise lies in lipid-based nanoparticles, transdermal and controlled drug delivery, nose-to-brain targeting, and nanomedicine for brain and tumour therapies. She has published over 50 international and 3 national papers in reputed SCI-indexed journals with an impact factor above 183, authored two books, contributed several book chapters, and holds patents. She has guided numerous postgraduate and doctoral students, completed government and institutional funded projects from DBT, AYUSH, and SVKM, and presented at national and international forums. Her achievements include multiple gold medals, the G.P. Nair Award from IDMA, outstanding performance awards, and recognition through fellowships and grants. She is actively involved in academic associations such as IPA, APTI, and MSU Alumni, while also serving on editorial boards and advisory roles, making impactful contributions to pharmaceutical sciences through teaching, research, innovation, and community development.

Profiles: Scopus | Google Scholar | Orcid

Featured Publication

Goyal, S. N., Reddy, N. M., Patil, K. R., Nakhate, K. T., Ojha, S., Patil, C. R., … Agrawal, Y. O. (2016). Challenges and issues with streptozotocin-induced diabetes–A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics. Chemico-Biological Interactions, 244, 49–63.

Agrawal, Y., Petkar, K. C., & Sawant, K. K. (2010). Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis. International Journal of Pharmaceutics, 401(1–2), 93–102.

Agrawal, Y. O., Sharma, P. K., Shrivastava, B., Ojha, S., Upadhya, H. M., Arya, D. S., … Goyal, S. N. (2014). Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic rats. PLOS ONE, 9(11), e111212.

Goyal, S. N., Sharma, C., Mahajan, U. B., Patil, C. R., Agrawal, Y. O., Kumari, S., … Ojha, S. (2015). Protective effects of cardamom in isoproterenol-induced myocardial infarction in rats. International Journal of Molecular Sciences, 16(11), 27457–27469.

Eddin, L. B., Jha, N. K., Goyal, S. N., Agrawal, Y. O., Subramanya, S. B., Bastaki, S. M. A., … Ojha, S. (2022). Health benefits, pharmacological effects, molecular mechanisms, and therapeutic potential of α-bisabolol. Nutrients, 14(7), 1370.